Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124720802 | 12472080 | 2 | F | 20160721 | 20160616 | 20160722 | EXP | US-JNJFOC-20160610322 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124720802 | 12472080 | 1 | SS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | N | UNKNOWN | 0 | 54 | MG | SUSTAINED RELEASE TABLETS | QD | ||||
| 124720802 | 12472080 | 2 | SS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | N | UNKNOWN | 0 | 18 | MG | SUSTAINED RELEASE TABLETS | QD | ||||
| 124720802 | 12472080 | 3 | SS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | N | UNKNOWN | 0 | 54 | MG | SUSTAINED RELEASE TABLETS | QD | ||||
| 124720802 | 12472080 | 4 | SS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | N | UNKNOWN | 0 | 54 | MG | SUSTAINED RELEASE TABLETS | QD | ||||
| 124720802 | 12472080 | 5 | PS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | N | UNKNOWN | 21121 | 27 | MG | SUSTAINED RELEASE TABLETS | QD | ||||
| 124720802 | 12472080 | 6 | SS | METHYLPHENIDATE HYDROCHLORIDE. | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | 0 | 54 | MG | TABLETS | QD | ||||||
| 124720802 | 12472080 | 7 | SS | METHYLPHENIDATE HYDROCHLORIDE. | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | 0 | 54 | MG | TABLETS | QD | ||||||
| 124720802 | 12472080 | 8 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | U | 0 | 10 | MG | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124720802 | 12472080 | 1 | Attention deficit/hyperactivity disorder |
| 124720802 | 12472080 | 2 | Attention deficit/hyperactivity disorder |
| 124720802 | 12472080 | 3 | Attention deficit/hyperactivity disorder |
| 124720802 | 12472080 | 4 | Attention deficit/hyperactivity disorder |
| 124720802 | 12472080 | 5 | Attention deficit/hyperactivity disorder |
| 124720802 | 12472080 | 6 | Attention deficit/hyperactivity disorder |
| 124720802 | 12472080 | 7 | Attention deficit/hyperactivity disorder |
| 124720802 | 12472080 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124720802 | 12472080 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124720802 | 12472080 | Discomfort | |
| 124720802 | 12472080 | Drug ineffective | |
| 124720802 | 12472080 | Drug titration error | |
| 124720802 | 12472080 | Mammoplasty | |
| 124720802 | 12472080 | Nervousness | |
| 124720802 | 12472080 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124720802 | 12472080 | 3 | 20160608 | 0 | ||
| 124720802 | 12472080 | 4 | 2012 | 2016 | 0 | |
| 124720802 | 12472080 | 6 | 20160506 | 20160607 | 0 | |
| 124720802 | 12472080 | 7 | 2012 | 2012 | 0 |